NR vs NMN vs Niacin: Comparing NAD+ Precursors
These compounds all feed the same pathway. They differ in how much human evidence exists, how they are regulated and what they cost.
By Hypergevity Editorial Team · Published September 3, 2026 · Updated September 3, 2026 · 7 min read
- NAD+ itself is poorly absorbed as a supplement, so products sell precursors instead.
- Niacin and nicotinamide are established B3 forms with defined nutrient requirements.
- NR and NMN can raise blood NAD+ markers in human trials; clinical outcome benefits are not established.
- NMN's status as a lawful dietary supplement ingredient in the U.S. has been contested.
- No precursor has been shown to extend healthspan or lifespan in humans.
Every product in this category is trying to raise NAD+, a coenzyme central to energy metabolism and cellular repair. Because NAD+ does not survive digestion intact in a useful way, supplements supply precursors that the body converts. The marketing differences between them are far larger than the demonstrated clinical differences.
Side by side
| Compound | What it is | Human evidence | Notes |
|---|---|---|---|
| Niacin (nicotinic acid) | Established form of vitamin B3 | Well studied as a nutrient; high doses studied for lipids | Flushing is common at higher doses; liver considerations with sustained-release forms |
| Nicotinamide (niacinamide) | Established form of vitamin B3 | Well studied as a nutrient | No flushing; upper intake limits still apply |
| Nicotinamide riboside (NR) | Precursor sold as a supplement | Trials show it can raise NAD+ markers; outcome benefits not established | The most studied of the newer precursors |
| Nicotinamide mononucleotide (NMN) | Precursor sold as a supplement | Limited human data | U.S. regulatory status as a dietary supplement ingredient has been contested |
| IV NAD+ | Infusion offered by clinics | Marketed claims exceed published human evidence | Adds procedural risk and cost |
A trial showing higher blood NAD+ after supplementation answers a chemistry question. Whether that changes energy, cognition, aging or disease risk is a separate question that current human evidence does not settle.
How to read a label in this category
- Check that the compound and dose are stated per serving, not just per bottle
- Look for independent third-party testing for identity and purity
- Check whether cited studies were in humans, at that dose, for a meaningful duration
- Treat claims to treat, cure or prevent disease as a warning sign — those are drug claims
- Disclose everything you take to your clinician, especially alongside prescription medication
Where the money is better spent first
The interventions with the strongest evidence for healthy aging are unglamorous: resistance training and cardiovascular exercise, adequate protein, sleep, blood pressure and glucose control, not smoking, and keeping up with preventive screening. Precursor supplements are an addition to that base, not a substitute for it.
For the broader evidence picture, see our guides on NAD+ supplement claims and evaluating longevity claims.
Frequently asked questions
- Is NMN better than NR?
- Human evidence does not establish that. NR has been studied more in people, and NMN's U.S. supplement status has been contested, so availability and quality vary.
- Can I just take niacin instead?
- Niacin is an established NAD+ precursor and a recognised nutrient, but high doses have their own effects such as flushing and liver considerations. Discuss dosing with a clinician.
- Do any of these extend lifespan?
- No precursor has been shown to extend healthspan or lifespan in humans. Striking results largely come from cell and animal studies.
Review your stack with a clinician
Hypergevity clinical care includes reviewing what you already take. Start a confidential intake to discuss it with a licensed U.S. provider.
References
- Niacin — Office of Dietary Supplements, National Institutes of Health
- Dietary Supplements: What You Need to Know — Office of Dietary Supplements, National Institutes of Health
- What Do We Know About Healthy Aging? — National Institute on Aging (NIH)
Prescription products require an online consultation with a healthcare professional who will determine if a prescription is appropriate. You will be notified through email, text/SMS, or your online Hypergevity portal if approved. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. If receiving treatment for other conditions, your provider may prescribe FDA-approved generic or brand prescription drugs. If you are unsure, always ask your provider which medication they are prescribing.